Advertisement
News
Subscribe to MDT Magazine News

PolyRemedy sews up $20M financing round

June 7, 2011 6:35 am | by Mass High Tech: The Journal of New England Technology | Comments

PolyRemedy Inc., a personalized wound care company based in Boston and Mountain View, Calif., has closed a $20 million Series C funding round. The company also named Cameron McKennitt as chief commercial officer of the company's sales and marketing.

Oridion Medical and Philips Healthcare Microstream CO2 Filterline (FilterLine H Set Infant/Neonate, VitaLine H Set Infant/Neonate: Recall - Plastic Strands on the Adapter May ...

June 7, 2011 6:30 am | by U.S. Food & Drug Administration | Comments

Inhalation of the plastic strands may cause respiratory compromise, which could result in serious illness or death.

Biogen Idec says EU regulators approved Avonex pen

June 7, 2011 3:45 am | by The Associated Press | Comments

Biogen Idec Inc. said Tuesday that European Union regulators approved an injectable pen version of its multiple sclerosis drug Avonex.The Avonex Pen is approved for patients who have experienced the first symptoms of MS, or who have the relapsing form of the disease. The pens are single-use...

Advertisement

Vendor Neutral Archiving: What the NHS Should Expect

June 7, 2011 3:31 am | by RealWire | Comments

Free whitepaper from BridgeHead Software explains how vendor neutral archives (VNAs) can help the NHS reduce IT costs, increase efficiency and improve data protectionAshtead, UK - Tuesday 7th June - BridgeHead Software, a leader in healthcare data and storage management, today released a...

TOPICS:

VEGF Trap-Eye Submitted for EU Marketing Authorization for Treatment of Wet Age-Related Macular Degeneration

June 6, 2011 11:33 pm | by Bio-Medicine.Org | Comments

TARRYTOWN, N.Y. and BERLIN, June 7, 2011 /- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) and Bayer HealthCare today announced that Bayer HealthCare has submitted an application for marketing authorization in Europe for VEGF Trap-Eye for the treatment of the neovascular form of...

TOPICS:

Apricoxib Prolongs Time-to-Progression and Overall Survival in Biomarker-Selected NSCLC Patients

June 6, 2011 5:33 pm | by Bio-Medicine.Org | Comments

CHICAGO and SAN DIEGO, June 6, 2011 /- Tragara Pharmaceuticals, Inc. announced today that apricoxib (Capoxigem®, TG01) in combination with erlotinib demonstrated significant and consistent clinical benefit over erlotinib alone in a clinically relevant subset of biomarker-selected...

OSRAM initiates patent infringement litigation against Samsung and LG(2)

June 6, 2011 4:38 pm | by I-Micronews | Comments

OSRAM has filed legal actions against Samsung group companies and LG group companies in the US and Germany as well as against an LG group company in Japan.

OSRAM initiates patent infringement litigation against Samsung and LG

June 6, 2011 4:37 pm | Comments

OSRAM has filed legal actions against Samsung group companies and LG group companies in the US and Germany as well as against an LG group company in Japan.

Advertisement

SensorDynamics: New SD746 features wake-up on motion function

June 6, 2011 3:37 pm | by I-Micronews | Comments

The 6DoF-IMU* SD746, designed for motion measurement in consumer and industrial applications, now comes with a low current consumption sleep mode allowing system wake-up by motion detection.

Microwave plasma system - GIGAfab A by PVA TePla(2)

June 6, 2011 3:36 pm | by I-Micronews | Comments

Microwave plasma system GIGAfab A200/300.

Microwave plasma system - GIGAfab A by PVA TePla

June 6, 2011 3:35 pm | Comments

Microwave plasma system GIGAfab A200/300.

Cancer test maker DiagnoCure loses $1.6 million in Q2, down from last year

June 6, 2011 2:45 pm | by The Associated Press | Comments

Cancer diagnostic test-maker DiagnoCure Inc. (TSX:CUR) narrowed its second quarter loss on bigger royalty revenues from two of its products and lower research and development expenses.The Quebec City-based maker of cancer diagnostic tests and provider of laboratory services, says it had a net...

CMSF Corporation merges with Plures Technologies, Inc., a specialized semiconductor company

June 6, 2011 2:37 pm | by I-Micronews | Comments

CMSF Corporation (OTCBB:CMSF) has no significant operations.

The Premier Basketball League Brings on Key Health Industry Sponsorship for 2012

June 6, 2011 2:35 pm | by Bio-Medicine.Org | Comments

CHICAGO, June 6, 2011 /- The Premier Basketball League announced today that Scientific Imaginetics® , the global leader in non-invasive pain relief technology, has come on board as a corporate sponsor for the 2012 PBL season. Scientific Imaginetics' TMR® technology is a...

Crux Successfully Completes Funding for Advanced Filter for PE Prevention

June 6, 2011 2:34 pm | by Bio-Medicine.Org | Comments

MENLO PARK, Calif., June 6, 2011 /- Crux Biomedical Inc., a developer of an advanced implantable vena cava filter (VCF), announced the successful completion a $12.0MM investment round.  The round was led by Three Arch Partners, which was joined by current investors, Alloy Ventures...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading